Header Logo

Connection

Zoe Arvanitakis to Cognitive Dysfunction

This is a "connection" page, showing publications Zoe Arvanitakis has written about Cognitive Dysfunction.
Connection Strength

1.962
  1. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.482
  2. Insulin resistance, cognition, and Alzheimer disease. Obesity (Silver Spring). 2023 06; 31(6):1486-1498.
    View in: PubMed
    Score: 0.470
  3. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.354
  4. Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018 01 16; 73(2):198-203.
    View in: PubMed
    Score: 0.324
  5. A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
    View in: PubMed
    Score: 0.099
  6. Changes in Body Mass Index Are Related to Faster Cognitive Decline Among African American Older Adults. J Am Geriatr Soc. 2020 11; 68(11):2662-2667.
    View in: PubMed
    Score: 0.097
  7. Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016 Oct 18; 87(16):1681-1687.
    View in: PubMed
    Score: 0.074
  8. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.